Ali Haider Zakir, MD | |
19121 W Little York Rd, Suite B, Katy, TX 77449-5840 | |
(713) 955-5200 | |
(281) 858-1251 |
Full Name | Ali Haider Zakir |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 21 Years |
Location | 19121 W Little York Rd, Katy, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124128673 | NPI | - | NPPES |
194406802 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | M3434 (Texas) | Secondary |
207R00000X | Internal Medicine | M3434 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hca Houston Healthcare Tomball | Tomball, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Zealth Care Pllc | 7416189774 | 3 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Precyse, an industry leader in Health Information Management (HIM) performance solutions, is pleased to announce Precyse's Clinical Documentation Improvement services received high scores in a recent KLAS report, titled "CDI Services 2014: Providing Light to Documentation Darkness."
At least 15 million people in the U.S. experience diminished quality of life due to excessive sweating, or hyperhidrosis.
Reduced nicotine metabolism is associated with a greater number of cigarettes smoked per day and increased levels of dependence in adolescent smokers, researchers report.
› Verified 5 days ago
Entity Name | Memorial Hermann Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Precyse, an industry leader in Health Information Management (HIM) performance solutions, is pleased to announce Precyse's Clinical Documentation Improvement services received high scores in a recent KLAS report, titled "CDI Services 2014: Providing Light to Documentation Darkness."
At least 15 million people in the U.S. experience diminished quality of life due to excessive sweating, or hyperhidrosis.
Reduced nicotine metabolism is associated with a greater number of cigarettes smoked per day and increased levels of dependence in adolescent smokers, researchers report.
› Verified 5 days ago
Entity Name | Zealth Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255767687 PECOS PAC ID: 7416189774 Enrollment ID: O20140421000938 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Precyse, an industry leader in Health Information Management (HIM) performance solutions, is pleased to announce Precyse's Clinical Documentation Improvement services received high scores in a recent KLAS report, titled "CDI Services 2014: Providing Light to Documentation Darkness."
At least 15 million people in the U.S. experience diminished quality of life due to excessive sweating, or hyperhidrosis.
Reduced nicotine metabolism is associated with a greater number of cigarettes smoked per day and increased levels of dependence in adolescent smokers, researchers report.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ali Haider Zakir, MD 19121 W Little York Rd, Suite B, Katy, TX 77449-5840 Ph: (713) 955-5200 | Ali Haider Zakir, MD 19121 W Little York Rd, Suite B, Katy, TX 77449-5840 Ph: (713) 955-5200 |
News Archive
Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, announced the establishment of an agreement with Cephalon, Inc., a global biopharmaceutical company, for the testing of the Cephalon novel B-Raf inhibitor CEP-32496 in Champions' Biomerk Tumorgraft™ platform.
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Precyse, an industry leader in Health Information Management (HIM) performance solutions, is pleased to announce Precyse's Clinical Documentation Improvement services received high scores in a recent KLAS report, titled "CDI Services 2014: Providing Light to Documentation Darkness."
At least 15 million people in the U.S. experience diminished quality of life due to excessive sweating, or hyperhidrosis.
Reduced nicotine metabolism is associated with a greater number of cigarettes smoked per day and increased levels of dependence in adolescent smokers, researchers report.
› Verified 5 days ago
Yumna Ghouri, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 23900 Katy Fwy, Katy, TX 77494 Phone: 281-644-8111 Fax: 281-644-8144 | |
Dr. Shazia F Sheikh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23211 Red River Dr, Katy, TX 77494 Phone: 832-437-2427 Fax: 281-396-4798 | |
Dr. Gurjyot Kaur Doshi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1331 W Grand Pkwy N, Suite 340, Katy, TX 77493 Phone: 281-392-2757 Fax: 281-392-8148 | |
Alvin Raymond Co Tan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
William Alexander Currie, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21700 Kingsland Blvd, Suite 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-398-6320 | |
Ebba M Tsinopoulos, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 21720 Kingsland Blvd, Katy, TX 77450 Phone: 212-409-6121 Fax: 405-745-9602 | |
Jennifer Leigh Thomas, NP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20710 Westheimer Pkwy, Katy, TX 77450 Phone: 936-277-1000 Fax: 936-994-9020 |